This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Sat May 18, 2013 3:41 am


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 2 posts ] 
Author Message
PostPosted: Thu Dec 13, 2007 9:46 am 
Offline
Family Elder
User avatar

Joined: Wed Aug 11, 2004 3:00 pm
Posts: 1610
A drug that's been discussed a bit lately here. Azathioprine has been used off-label for MS since the 60s or 70s. Maybe it's not a bad option as it is a pill. Balance that off with more serious side-effects because it's an immunosuppressant.



Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis.

J Neurol. 2007 Dec 14 [Epub ahead of print]
Etemadifar M, Janghorbani M, Shaygannejad V.
Dept. of Neurology and Epidemiology, Isfahan University of Medical Sciences and Health Services, Iran.

We compared the relative efficacy of interferon beta (IFNbeta) products and azathioprine (AZA) in the treatment of relapsing- remitting multiple sclerosis (RRMS). Ninety-four previously untreated patients of short duration with RRMS were randomly allocated to the two treatment groups. The first group received IFNbeta products (Betaferon,Avonex or Rebif); the second group received AZA for 12 months. Response to treatment was assessed at 3, 6, and 12 months after starting therapy.

The mean number of relapse during one year of the study was lower in the AZA group than in the IFNbeta products group (0.28 vs. 0.64, P < 0.05). After 12 months, 57.4% of patients receiving IFNbeta products remained relapse free compared with 76.6% of those given AZA. The Expanded Disability Status Scale (EDSS) decreased by 0.30 units in IFNbeta-treated patients (P < 0.05) and 0.46 in AZAtreated patients (P < 0.001). Treatment with IFNbeta products and AZA significantly reduces the relapse rate and EDSS score in patients with RRMS, while AZA is more effective than the IFNbeta formulations.

Pubmed link


Last edited by dignan on Thu Dec 13, 2007 10:05 pm, edited 1 time in total.

Top
 Profile  
 
 Post subject: Azathioprine (Imuran)
PostPosted: Thu Dec 13, 2007 7:27 pm 
Offline
Family Elder
User avatar

Joined: Thu Dec 22, 2005 4:00 pm
Posts: 1663
Every mention of azathioprine (Imuran) makes me nervous because of reading of suspicion that it causes cancer (Three mentions were in The Autoimmune Connection) and because a dear friend with another autoimmune disease (myasthenia gravis, also known as MG) died of cancer in the liver and colon after taking Imuran about one year.

I urge anyone who considers taking it to be very informed, cautious, and alert to possible problems.


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 2 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. MN 166 trial results

bromley

4

1272

Wed Mar 28, 2007 8:13 am

dignan View the latest post

There are no new unread posts for this topic. Daclizumab trial results

dignan

4

1581

Tue Mar 13, 2007 6:42 am

Lyon View the latest post

There are no new unread posts for this topic. Clinical trial results

dignan

6

1828

Wed Apr 04, 2007 4:24 am

carolew View the latest post

There are no new unread posts for this topic. Minocycline trial results

dignan

13

3847

Wed Jun 06, 2007 7:29 am

viper498 View the latest post

There are no new unread posts for this topic. Laquinimod trial results

bromley

3

1419

Wed May 02, 2007 4:18 pm

TonyJegs View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: